Clinical Trials Directory

Trials / Conditions / Zika Virus

Zika Virus

22 registered clinical trials studyying Zika Virus — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSerological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-b
NCT06859619
University Hospital, MontpellierN/A
CompletedEvaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Cha
NCT06805487
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedEvaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)
NCT05123222
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedA Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
NCT04917861
ModernaTX, Inc.Phase 2
Enrolling By InvitationNeurodevelopmental Outcomes in ZIKV-Exposed Children
NCT04398901
Children's National Research Institute—
CompletedEvaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua
NCT04182685
RTI International—
CompletedSafety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Sero
NCT04064905
ModernaTX, Inc.Phase 1
CompletedSafety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults
NCT03611946
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
WithdrawnZIKAlliance Natural History Study
NCT03204409
University of Heidelberg Medical Center—
CompletedRandomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika V
NCT03425149
Valneva Austria GmbHPhase 1
CompletedZIKAlliance Children Cohort (ZIKAllianceCH)
NCT03393286
University of Heidelberg Medical Center—
CompletedProspective Cohort Study of HIV and Zika in Infants and Pregnancy
NCT03263195
Westat—
CompletedStudy on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
NCT03106714
Oswaldo Cruz Foundation—
UnknownEffect of a Posture Adapter for 12 to 24-month Children With Zyka Virus Syndrome
NCT03227601
Universidade Federal de PernambucoN/A
CompletedZIKAlliance Pregnant Women Cohort
NCT03188731
University of Heidelberg Medical Center—
CompletedZika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)
NCT02996890
Themis Bioscience GmbHPhase 1
CompletedVRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
NCT03110770
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedSafety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
NCT03014089
ModernaTX, Inc.Phase 1
CompletedUnderstanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
NCT02979938
Trinidad and Tobago IVF and Fertility Centre—
CompletedZika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
NCT02794181
National Institutes of Health Clinical Center (CC)—
CompletedPersistence of Zika Virus in Semen After Acute Infection
NCT02733796
Institute of Tropical Medicine, Belgium—
UnknownCohort of Patients Infected by an Arbovirus
NCT01099852
University Hospital Center of Martinique—